315 related articles for article (PubMed ID: 29857164)
1. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery systems using polymer nanoassemblies for cancer treatment.
Bae Y
Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
[No Abstract] [Full Text] [Related]
4. Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges.
Bose RJC; Ravikumar R; Karuppagounder V; Bennet D; Rangasamy S; Thandavarayan RA
Drug Discov Today; 2017 Aug; 22(8):1258-1265. PubMed ID: 28600191
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
[TBL] [Abstract][Full Text] [Related]
6. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
8. EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors.
Stylianopoulos T
Ther Deliv; 2013 Apr; 4(4):421-3. PubMed ID: 23557281
[No Abstract] [Full Text] [Related]
9. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
10. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
[TBL] [Abstract][Full Text] [Related]
11. Nanospray Drying Technology: Existing Limitations and Future Challenges.
Wui WT
Recent Pat Drug Deliv Formul; 2015; 9(3):185-6. PubMed ID: 25966873
[No Abstract] [Full Text] [Related]
12. Nanomedicine: An effective tool in cancer therapy.
Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
[TBL] [Abstract][Full Text] [Related]
13. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
14. Lipid-enveloped hybrid nanoparticles for drug delivery.
Tan S; Li X; Guo Y; Zhang Z
Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanomedicines for anticancer drug therapy.
Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Prieto MJ
J Biomed Nanotechnol; 2009 Aug; 5(4):323-43. PubMed ID: 20055079
[TBL] [Abstract][Full Text] [Related]
16. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
Heneweer C; Gendy SE; Peñate-Medina O
Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
[TBL] [Abstract][Full Text] [Related]
17. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy.
Ganta S; Talekar M; Singh A; Coleman TP; Amiji MM
AAPS PharmSciTech; 2014 Jun; 15(3):694-708. PubMed ID: 24510526
[TBL] [Abstract][Full Text] [Related]
18. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
19. Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.
Gajbhiye KR; Salve R; Narwade M; Sheikh A; Kesharwani P; Gajbhiye V
Mol Cancer; 2023 Oct; 22(1):160. PubMed ID: 37784179
[TBL] [Abstract][Full Text] [Related]
20. Nanooncology: the future of cancer diagnosis and therapy.
Thakor AS; Gambhir SS
CA Cancer J Clin; 2013; 63(6):395-418. PubMed ID: 24114523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
